{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T06:08:52Z","timestamp":1777874932452,"version":"3.51.4"},"reference-count":10,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinecjc.ca","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.cjca.2025.08.335","type":"journal-article","created":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T20:50:04Z","timestamp":1755809404000},"page":"2334-2336","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Practical Guide to the Management of Residual Obstruction After Alcohol Septal Ablation in Patients With Obstructive Hypertrophic Cardiomyopathy"],"prefix":"10.1016","volume":"41","author":[{"given":"Josef","family":"Veselka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2025.08.335_bib1","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1016\/j.jacc.2024.02.014","article-title":"2024 AHA\/ACC\/AMSSM\/HRS\/PACES\/SCMR guideline for the management of hypertrophic cardiomyopathy","volume":"83","author":"Ommen","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2025.08.335_bib2","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0140-6736(16)31321-6","article-title":"Hypertrophic obstructive cardiomyopathy","volume":"389","author":"Veselka","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2025.08.335_bib3","first-page":"133","article-title":"Biphasic course of changes of left ventricular outflow gradient after alcohol septal ablation for hypertrophic obstructive cardiomyopathy","volume":"60","author":"Veselka","year":"2004","journal-title":"Kardiol Pol"},{"key":"10.1016\/j.cjca.2025.08.335_bib4","first-page":"2397","article-title":"Percutaneous intramyocardial septal radiofrequency ablation for hypertrophic cardiomyopathy with residual obstruction after alcohol septal ablation","volume":"12","author":"Zhang","year":"2025","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2025.08.335_bib5","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.5114\/aoms.2020.97969","article-title":"Long-term outcome of repeated septal reduction therapy after alcohol septal ablation for hypertrophic obstructive cardiomyopathy: insight from the Euro-ASA registry","volume":"16","author":"Veselka","year":"2020","journal-title":"Arch Med Sci"},{"key":"10.1016\/j.cjca.2025.08.335_bib6","first-page":"833","article-title":"Interventions in hypertrophic obstructive cardiomyopathy","volume":"40","author":"Ding","year":"2024","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2025.08.335_bib7","first-page":"1457","article-title":"Comparison of percutaneous endocardial septal radiofrequency ablation with alcohol septal ablation in treating hypertrophic obstructive cardiomyopathy","volume":"412","author":"Tian","year":"2025","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2025.08.335_bib8","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1056\/NEJMoa2401424","article-title":"Aficamten for symptomatic obstructive hypertrophic cardiomyopathy","volume":"390","author":"Maron","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cjca.2025.08.335_bib9","first-page":"1303","article-title":"Personalized treatment of severe obstructive hypertrophic cardiomyopathy: Combining septal reduction therapy and myosin inhibitors","volume":"41","author":"Veselka","year":"2025","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2025.08.335_bib10","first-page":"860","article-title":"Mitral valve interventions for hypertrophic obstructive cardiomyopathy","volume":"40","author":"Shuvy","year":"2024","journal-title":"Can J Cardiol"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X25010189?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X25010189?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T20:34:11Z","timestamp":1777581251000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X25010189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":10,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S0828282X25010189"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2025.08.335","relation":{},"ISSN":["0828-282X"],"issn-type":[{"value":"0828-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Practical Guide to the Management of Residual Obstruction After Alcohol Septal Ablation in Patients With Obstructive Hypertrophic Cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2025.08.335","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2025.08.355","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}